US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 20.650
  • -0.580-2.73%
Close Feb 25 16:00 ET
  • 22.194
  • +1.544+7.48%
Post 20:01 ET
1.83BMarket Cap-5.06P/E (TTM)

Travere Therapeutic Key Stats

Travere Therapeutic Q4 2024 Earnings Date

Currency:USDFeb 20, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
72.38M
74.79M
+2.41M
Beat Est.
+60.62%
+65.98%
+3.33%
EPS
-0.57
-0.73
-0.16
Miss Est.
+51.78%
+38.14%
-28.30%
Strong Buy

Feb 24, 2025

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 89.562M--
--2025/Q1-- / 77.525M--
Feb 20, 20252024/Q474.787M / 72.375M--
Oct 31, 20242024/Q362.898M / 60.831M--
Aug 1, 20242024/Q254.116M / 52.686M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 89.562M--
--2025/Q1-- / 77.525M--
Feb 20, 20252024/Q474.787M / 72.375M--
Oct 31, 20242024/Q362.898M / 60.831M--
Aug 1, 20242024/Q254.116M / 52.686M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

Read more

Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Feb 24, 2025

Strong Buy

  • Buy

    92.31%
  • Hold

    7.69%
  • Sell

    0.00%

Price Target

No Data